Macrogen Launches Special Promotion on Exome Sequencing to Celebrate Their 20th Anniversary
Macrogen Inc. (CEO Hyon-yong Chong, www.macrogen.com ) (KOSDAQ:038290), a precision medicine biotechnology company, announced on June 1st that it is launching a special promotion on Exome Sequencing to celebrate their 20th anniversary.
During this special promotion period, Macrogen will offer Exome Sequencing service with 100x coverage using SureSelect Human All Exon V5 (50M) or V6 (58M) capture kit at a special price of $299 per sample. This is an innovative price that has never been offered anywhere else before. Through this promotion, researchers around the world can take advantage of Macrogen’s Exome service that is known for its high-quality data and fast Turnaround Time (TAT) on very special price terms.
Macrogen has obtained the highest level of genome analysis technology in the world through continuous technological development and research activities for the past 20 years. In 2016, Macrogen established the world's highest-precision reference of a Korean genome (Nature, 2016) and has since been recognized globally for its outstanding academic capacity and technology. Furthermore, in order to strengthen its position as the technological leader, Macrogen purchased the latest sequencing equipment, NovaSeq6000 (Illumina Inc.). This enables Macrogen to analyze over 70,000 human genomes, or 8,000Tb per year.
Macrogen’s CEO Hyon-yong Chong said, "This Exome promotion is not only to celebrate the 20th anniversary of Macrogen, but is also to satisfy our customers with its competitive edge in low price and top-notch analytical service." Chong added, "Macrogen will always strive to provide services that our customers can value."
For further details on this promotion, please refer to below link:
For details on service and ordering, please contact email@example.com .
Macrogen is a leading service provider of integrated genomic research dedicated to providing the highest quality genomics services. Macrogen provide a wide range of sequencing and bioinformatics services to the academic, pharmaceutical, and clinical research communities around the world. For more information on Macrogen, please visit www.macrogen.com .
Elena J Kim, +82-2-2113-7355
NGS overseas sales & marketing division
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Ved at skrive dig op her, vil du modtage pressemeddelelser på mail når de udsendes. Indtast din mail og følg instruktionerne. Det er ligeså let at melde sig fra igen.
Flere pressemeddelelser fra Business Wire
PA-WESTINGHOUSE-ELECTRIC20.10.2017 14:17 | pressemeddelelse
Westinghouse Receives Regulatory Approval for Analysis Methodologies
CA-GILEAD-SCIENCES20.10.2017 14:05 | pressemeddelelse
Gilead Announces Multiple Scientific Presentations Demonstrating High Cure Rates in Difficult-to-Cure HCV Patients and Improved Long-Term Bone and Renal Safety of Vemlidy® in HBV Patients Switched from Viread®
TX-SCHLUMBERGER-LIMITED20.10.2017 13:02 | pressemeddelelse
Schlumberger Announces Third-Quarter 2017 Results
SP3H20.10.2017 12:49 | pressemeddelelse
SP3H Announces That It Has Obtained a €1.2 Million European Union Grant for Its Intelligent and Clean Vehicle (VIP) Project
CA-KENNEDY-WILSON20.10.2017 12:02 | pressemeddelelse
Kennedy Wilson and Kennedy Wilson Europe Real Estate Plc Complete Merger, Creating $8 Billion Global Real Estate Company
WTC-GIBRALTAR20.10.2017 11:50 | pressemeddelelse
World Trade Center Gibraltar: £65m Annual Boost to Local Economy
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum